The Asia-Pacific (APAC) orthobiologics market is experiencing rapid growth, driven by technological innovations in regenerative medicine, an aging population, and increasing demand for minimally invasive treatments. Orthobiologics refers to the use of biological substances to promote healing in musculoskeletal conditions, including bone fractures, joint injuries, and cartilage damage. These therapies harness the body’s natural healing abilities and are transforming the way orthopedic conditions are treated across the region.